AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
10.88
-0.53 (-4.61%)
Oct 13, 2026, 3:47 PM EDT - Market open
AngioDynamics Financials Overview
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Revenue Revenue Growth | 325.38 | 320.17 | 292.5 | 303.91 | 338.75 | 316.22 |
Revenue Growth | 8.20% | 9.46% | -3.76% | -10.28% | 7.13% | 8.66% |
Gross Profit Gross Profit Growth | 179.88 | 174.89 | 157.71 | 154.7 | 174.25 | 165.73 |
Operating Income Operating Income Growth | -20.89 | -22.47 | -23.57 | -33.96 | -19.31 | -18.22 |
Net Income Net Income Growth | -32.94 | -36.74 | -33.99 | -184.35 | -52.44 | -26.55 |
Earnings Per Share EPS Growth | -0.79 | -0.88 | -0.83 | -4.59 | -1.33 | -0.68 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Med Tech Med Tech Growth | 154.61 | 149.95 | 126.65 | 106.4 | 96.69 | 78.72 |
Med Device Med Device Growth | 170.77 | 170.22 | 165.85 | 197.51 | 242.07 | 237.5 |
Total Total Growth | 325.38 | 320.17 | 292.5 | 303.91 | 338.75 | 316.22 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Investments Cash & Investments Growth | 33.97 | 53.86 | 55.89 | 76.06 | 44.62 | 28.82 |
Total Debt Total Debt Growth | 10.74 | 10.96 | 10.15 | 5.91 | 55.06 | 32.26 |
Net Cash (Debt) Net Cash Growth | 23.23 | 42.91 | 45.75 | 70.14 | -10.44 | -3.44 |
Net Cash Growth | -20.33% | -6.21% | -34.78% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.56 | 1.03 | 1.12 | 1.75 | -0.26 | -0.09 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 3.67 | 3.09 | -10.13 | -28.16 | 0.08 | -7.19 |
Capital Expenditures CapEx Growth | -2.23 | -2.58 | -4.46 | -2.52 | -3.81 | -4.3 |
Free Cash Flow Free Cash Flow Growth | 1.44 | 0.51 | -14.59 | -30.68 | -3.73 | -11.49 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Gross Margin | 55.28% | 54.62% | 53.92% | 50.90% | 51.44% | 52.41% |
Operating Margin | -6.42% | -7.02% | -8.06% | -11.17% | -5.70% | -5.76% |
Pretax Margin | -10.07% | -11.34% | -11.63% | -63.06% | -16.07% | -9.47% |
Profit Margin | -10.12% | -11.48% | -11.62% | -60.66% | -15.48% | -8.39% |
FCF Margin | 0.44% | 0.16% | -4.99% | -10.09% | -1.10% | -3.63% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 13, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Forward PE | - | 104.96 | 104.96 | 104.96 | 104.96 | 287.20 |
P/FCF Ratio | 310.60 | 941.95 | - | - | - | - |
PS Ratio | 1.38 | 1.50 | 1.42 | 0.83 | 1.10 | 2.41 |